Data / Form D filings / Soricimed Biopharma Inc.
Soricimed Biopharma Inc.: Form D filings
Soricimed Biopharma Inc., a biotechnology company in Moncton, New Brunswick, Canada, filed 3 Form D notices with the SEC between 2011 and 2023. The latest, on January 19, 2023, reports $2.8 million sold of a $3.7 million offering to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18 BOTSFORD STREET, SUITE 201, Moncton, New Brunswick, Canada, E1C 4
- Phone
- (506) 856-0400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- New Brunswick, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1532755
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | Amendment | $3,732,179 | $2,775,233 | $956,946 | 45 | Jul 23, 2021 | sec.gov |
| Jan 31, 2022 | New notice | $3,929,597 | $1,414,655 | $2,514,942 | 42 | Jul 23, 2021 | sec.gov |
| Oct 18, 2011 | New notice | $109,000 | $109,000 | 2 | Sep 30, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Gunn | Executive Officer, Director | |
| Camille Belliveau | Director | |
| Marc Rubin | Director | |
| Susan Hicks | Director | |
| Robert Bruce | Executive Officer | |
| Jack Stewart | Executive Officer, Director | |
| Vaughn Embro-Pantelony | Director |
Every Form D from the week of Jan 16, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Soricimed Biopharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.